methylene blue has been researched along with a-Synucleinopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chasapopoulou, Z; Cranston, A; Frahm, S; Harrington, CR; Magbagbeolu, M; Riedel, G; Schwab, K; Theuring, F; Wischik, CM | 1 |
1 other study(ies) available for methylene blue and a-Synucleinopathies
| Article | Year |
|---|---|
Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
Topics: alpha-Synuclein; Animals; Glutamates; Humans; Methylene Blue; Mice; Mice, Transgenic; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Synucleinopathies | 2022 |